DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.                 )

Filed by the Registrant  ☒                            Filed by a Party other than the Registrant  ☐

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☒	Definitive Additional Materials
☐	Soliciting Material under §240.14a-12

CRESCENT ACQUISITION CORP

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒	No fee required.
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
☐	Fee paid previously with preliminary materials.
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing:
	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): May 24, 2021

Crescent Acquisition Corp

(Exact name of Registrant as specified in its charter)

Delaware	001-38825	82-3447941
(State of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

11100 Santa Monica Blvd., Suite 2000 Los Angeles, CA	90025
(Address of principal executive offices)	(Zip Code)

(310) 235-5900

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock and one-half of one redeemable Warrant	CRSAU	The NASDAQ Stock Market LLC
Class A common stock, $0.0001 par value per share	CRSA	The NASDAQ Stock Market LLC
Redeemable Warrants, each whole Warrant exercisable for one share of Class A common stock at an exercise price of $11.50	CRSAW	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Introductory Note

As previously disclosed, on January 13, 2021, Crescent Acquisition Corp, a Delaware corporation (“Crescent”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among Crescent, Function Acquisition I Corp, a Delaware corporation and a direct, wholly owned subsidiary of Crescent (“First Merger Sub”), Function Acquisition II LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of Crescent (“Second Merger Sub”), LiveVox Holdings, Inc., a Delaware corporation (“LiveVox”), and GGC Services Holdco, Inc., a Delaware corporation, which provides for, among other things: (a) the merger of First Merger Sub with and into LiveVox, with LiveVox being the surviving corporation of the merger and a direct, wholly owned subsidiary of Crescent as a consequence of the merger (the “First Merger”); and (b) immediately following the First Merger and as part of the same overall transaction as the First Merger, the merger of LiveVox with and into Second Merger Sub, with Second Merger Sub being the surviving corporation of the merger (together with the First Merger and collectively with the other transactions contemplated by the Merger Agreement, the “Business Combination”).

Item 8.01 Other Events.

On May 24, 2021, Crescent and LiveVox posted a webcast to discuss LiveVox’s first quarter 2021 financial results (the “Business Update Presentation”).

On May 24, 2021, Crescent issued a press release announcing the Business Update Presentation. The press release is attached as Exhibit 99.1 hereto and incorporated by reference herein.

The presentation used by Crescent and LiveVox in the Business Update Presentation is attached as Exhibit 99.2 hereto and incorporated by reference herein.

The transcript of the Business Update Presentation is attached as Exhibit 99.3 hereto and incorporated by reference herein.

Forward-Looking Statements

This report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be made directly in this report. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon management estimates and forecasts and reflect the views, assumptions, expectations, and opinions of Crescent or LiveVox, as the case may be, as of the date of this report, and may include, without limitation, changes in general economic conditions, including as a result of COVID-19, all of which are accordingly subject to change. Any such estimates, assumptions, expectations, forecasts, views or opinions set forth in this report constitute Crescent’s or LiveVox’s, as the case may be, judgments and should be regarded as indicative, preliminary and for illustrative purposes only. The forward-looking statements and projections contained in this report are subject to a number of factors, risks and uncertainties, some of which are not currently known to Crescent or LiveVox, that may cause Crescent’s or LiveVox’s actual results, performance or financial condition to be materially different from the expectations of future results, performance of financial condition. Although such forward-looking statements have been made in good faith and are based on assumptions that Crescent or LiveVox, as the case may be, believe to be reasonable, there is no assurance that the expected results will be achieved. Crescent’s and LiveVox’s actual results may differ materially from the results discussed in forward-looking statements. Additional information on factors that may cause actual results and Crescent’s performance to differ materially is included in Crescent’s periodic reports filed with the SEC, including but not limited to Crescent’s Amendment No. 1 to its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020. Copies of Crescent’s filings with the SEC are available publicly on the SEC’s website at www.sec.gov or may be obtained by contacting Crescent. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking statements are made only as of the date hereof, and neither Crescent nor LiveVox undertake any obligations to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Additional Information about the Business Combination and Where to Find It

This report may be deemed solicitation material in respect of the proposed Business Combination between Crescent and LiveVox. The Business Combination will be submitted to the stockholders of Crescent and LiveVox for their approval. In connection with such stockholder vote, Crescent filed with the Securities and Exchange Commission (the “SEC”) a proxy statement on Schedule 14A and mailed a definitive proxy statement to its stockholders in connection with Crescent’s solicitation of proxies for the special meeting of the stockholders of Crescent to be held to approve the Business Combination. This report does not contain all the information that should be considered concerning the proposed Business Combination and the other matters to be voted upon at the special meeting and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. Crescent’s stockholders and other interested parties are urged to read the proxy statement, the amendments thereto, the definitive proxy statement and any other relevant documents that are filed or furnished or will be filed or will be furnished with the SEC carefully and in their entirety in connection with Crescent’s solicitation of proxies for the special meeting to be held to approve the Business Combination and other related matters, as these materials contain important information about LiveVox and Crescent and the proposed Business Combination. The definitive proxy statement is being mailed to the stockholders of Crescent as of the record date established for voting on the proposed Business Combination and the other matters to be voted upon at the special meeting. Such stockholders may also obtain copies of the proxy statement, without charge, at the SEC’s website at http://www.sec.gov, at Crescent’s website at http://www.crescentspac.com or by directing a request to Crescent Acquisition Corp, 11100 Santa Monica Blvd., Suite 2000, Los Angeles, CA 90025.

No Offer or Solicitation

This report is for informational purposes only and does not constitute an offer or invitation for the sale or purchase of securities, assets or the business described herein or a commitment to Crescent or LiveVox with respect to any of the foregoing, and this filing shall not form the basis of any contract, nor is it a solicitation of any vote, consent, or approval in any jurisdiction pursuant to or in connection with the Business Combination or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Participants in the Solicitation

Crescent and LiveVox, and their respective directors and executive officers, may be deemed participants in the solicitation of proxies of Crescent’s stockholders in respect of the Business Combination. Information about the directors and executive officers of Crescent and of LiveVox and more detailed information regarding the identity of all potential participants, and their direct and indirect interests, by security holdings or otherwise, are set forth in the proxy statement for the Business Combination. Additional information regarding the identity of all potential participants in the solicitation of proxies to Crescent’s stockholders in connection with the proposed Business Combination and other matters to be voted upon at the special meeting, and their direct and indirect interests, by security holdings or otherwise, are included in the proxy statement that Crescent filed with the SEC. Investors may obtain such information by reading such proxy statement.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit     No.	Description
99.1	Press Release, dated as of May 24, 2021.
99.2	Business Update Presentation, dated as of May 24, 2021.
99.3	Transcript of Business Update Presentation, dated as of May 24, 2021.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 24, 2021

Crescent Acquisition Corp
/s/ George Hawley
Name:	George Hawley
Title:	General Counsel and Secretary

EX-99.1

Exhibit 99.1

Crescent Acquisition Corp and LiveVox Announce First Quarter 2021 Business Update

San Francisco, CA – Crescent Acquisition Corp (NASDAQ: CRSA) (“Crescent”), a publicly-traded special purpose acquisition company, and LiveVox Holdings, Inc. (“LiveVox”), a cloud-based provider of customer service and digital engagement tools, will post a webcast to discuss LiveVox’s first quarter 2021 financial results on Monday, May 24, 2021 at 8:30 a.m. EDT.

The conference call will be accessible via webcast on Crescent’s website under Investor Relations.

About LiveVox

LiveVox, a portfolio company of Golden Gate Capital, is a cloud-based contact center platform. By seamlessly integrating omnichannel communications, customer relationship management (CRM), and workforce optimization (WFO), LiveVox delivers exceptional agent and customer experiences, while helping to reduce compliance risk. LiveVox’s reliable, easy-to-use technology enables effective engagement strategies on channels of choice to help drive contact center performance. Founded in 2000, LiveVox is headquartered in San Francisco with offices in Atlanta, Denver, St. Louis, Colombia, and Bangalore. To learn more, visit www.livevox.com.

On January 14, 2021, LiveVox announced plans to merge with Crescent to become a publicly traded company (the “Business Combination”). Consummation of the Business Combination is subject to customary closing conditions, including approval by Crescent’s stockholders.

About Crescent Acquisition Corp

Crescent is a special purpose acquisition company formed by Crescent Capital, Robert D. Beyer and Todd M. Purdy for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or assets.

IMPORTANT LEGAL INFORMATION

Additional Information about the Proposed Transaction and Where to Find It

This communication may be deemed solicitation material in respect of the proposed Business Combination between Crescent and LiveVox. The Business Combination will be submitted to the stockholders of Crescent and LiveVox for their approval. In connection with such stockholder vote, Crescent filed with the Securities and Exchange Commission (the “SEC”) a proxy statement on Schedule 14A and mailed a definitive proxy statement to its stockholders in connection with Crescent’s solicitation of proxies for the special meeting of the stockholders of Crescent to be held to approve the Business Combination. This communication does not contain all the information that should be considered concerning the proposed Business Combination and the other matters to be voted upon at the special meeting and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. Crescent’s stockholders and other interested parties are urged to read the proxy statement, the amendments thereto, the definitive proxy statement and any other relevant documents that are filed or furnished or will be filed or will be furnished with the SEC carefully

and in their entirety in connection with Crescent’s solicitation of proxies for the special meeting to be held to approve the Business Combination and other related matters, as these materials contain important information about LiveVox and Crescent and the proposed Business Combination. The definitive proxy statement is being mailed to the stockholders of Crescent as of the record date established for voting on the proposed Business Combination and the other matters to be voted upon at the special meeting. Such stockholders may also obtain copies of the proxy statement, without charge, at the SEC’s website at http://www.sec.gov, at Crescent’s website at http://www.crescentspac.com or by directing a request to Crescent Acquisition Corp, 11100 Santa Monica Blvd., Suite 2000, Los Angeles, CA 90025.

Forward-Looking Statements

This communication contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be made directly in this communication. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon management estimates and forecasts and reflect the views, assumptions, expectations, and opinions of Crescent or LiveVox, as the case may be, as of the date of this communication, and may include, without limitation, changes in general economic conditions, including as a result of COVID-19, all of which are accordingly subject to change. Any such estimates, assumptions, expectations, forecasts, views or opinions set forth in this communication constitute Crescent’s or LiveVox’s, as the case may be, judgments and should be regarded as indicative, preliminary and for illustrative purposes only. The forward-looking statements and projections contained in this communication are subject to a number of factors, risks and uncertainties, some of which are not currently known to Crescent or LiveVox, that may cause Crescent’s or LiveVox’s actual results, performance or financial condition to be materially different from the expectations of future results, performance of financial condition. Although such forward-looking statements have been made in good faith and are based on assumptions that Crescent or LiveVox, as the case may be, believe to be reasonable, there is no assurance that the expected results will be achieved. Crescent’s and LiveVox’s actual results may differ materially from the results discussed in forward-looking statements. Additional information on factors that may cause actual results and Crescent’s performance to differ materially is included in Crescent’s periodic reports filed with the SEC, including but not limited to Crescent’s Amendment No. 1 to its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020. Copies of Crescent’s filings with the SEC are available publicly on the SEC’s website at www.sec.gov or may be obtained by contacting Crescent. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking statements are made only as of the date hereof, and neither Crescent nor LiveVox undertake any obligations to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

No Offer or Solicitation

This communication is for informational purposes only and does not constitute an offer or invitation for the sale or purchase of securities, assets or the business described herein or a commitment to Crescent or LiveVox with respect to any of the foregoing, and this filing shall not form the basis of any contract, nor is it a solicitation of any vote, consent, or approval in any jurisdiction pursuant to or in connection with the Business Combination or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Participants in Solicitation

Crescent and LiveVox, and their respective directors and executive officers, may be deemed participants in the solicitation of proxies of Crescent’s stockholders in respect of the Business Combination. Information about the directors and executive officers of Crescent and of LiveVox and more detailed information regarding the identity of all potential participants, and their direct and indirect interests, by security holdings or otherwise, are set forth in the proxy statement for the Business Combination. Additional information regarding the identity of all potential participants in the solicitation of proxies to Crescent’s stockholders in connection with the proposed Business Combination and other matters to be voted upon at the special meeting, and their direct and indirect interests, by security holdings or otherwise, are included in the proxy statement that Crescent filed with the SEC. Investors may obtain such information by reading such proxy statement.

Contacts:

For LiveVox:

Investors:

Alexis Waadt

Vice President, Head of Investor Relations

IR@livevox.com

Michael Bowen and Ryan Gardella

ICR, Inc. for LiveVox

livevoxIR@icrinc.com

Media:

Katie Creaser

LiveVoxPR@icrinc.com

For Crescent Acquisition Corp:

Investors:

Lasse Glassen

Addo Investor Relations

lglassen@addoir.com

424-238-6249

Media:

Bill Mendel

Mendel Communications

Bill@mendelcommunications.com

EX-99.2

May 2021 Business Update presentation Exhibit 99.2

Disclaimer This Management Presentation (this “Presentation”) has been prepared by LiveVox Holdings, Inc. and its affiliates (collectively, “LiveVox” or “Company”) and Crescent Acquisition Corp (“Crescent”) in connection with a proposed business combination involving Crescent and LiveVox as further described herein (the “Transaction”). This Presentation is for informational purposes only and does not constitute an offer or invitation for the sale or purchase of securities, assets or the business described herein or a commitment to Crescent or LiveVox with respect to any of the foregoing, and this Presentation shall not form the basis of any contract, nor is it a solicitation of any vote, consent, or approval in any jurisdiction pursuant to or in connection with the Transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. The terms "we", "us' and "our" in this Presentation refer to LiveVox or Crescent, depending on the context. This Presentation contains certain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may be made directly in this Presentation. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. All forward-looking statements and projections set forth in this Presentation are based upon management estimates and forecasts and reflect the views, assumptions, expectations, and opinions of Crescent or LiveVox, as the case may be, as of the date of this Presentation, and may include, without limitation, changes in general economic conditions, including as a result of COVID-19, all of which are accordingly subject to change. Any such estimates, assumptions, expectations, forecasts, views or opinions set forth in this Presentation constitute Crescent’s or LiveVox’s, as the case may be, judgments and should be regarded as indicative, preliminary and for illustrative purposes only. The forward-looking statements and projections contained in this Presentation are subject to a number of factors, risks and uncertainties, some of which are not currently known to Crescent or LiveVox, that may cause Crescent’s or LiveVox’s actual results, performance or financial condition to be materially different from the expectations of future results, performance of financial condition. Although such forward-looking statements and projections have been made in good faith and are based on assumptions that Crescent or LiveVox, as the case may be, believe to be reasonable, there is no assurance that the expected results will be achieved. Crescent’s and LiveVox’s actual results may differ materially from the results discussed in forward-looking statements. Additional information on factors that may cause actual results and Crescent’s performance to differ materially is included in Crescent’s reports filed with the Securities and Exchange Commission (“SEC”), including but not limited to Crescent’s definitive proxy statement on Schedule 14A relating to the Transaction (the “Proxy”) and Amendment No. 1 to Crescent's annual report on Form 10-K/A for the year ended December 31, 2020. Additional information on factors that may cause actual results and LiveVox’s performance to differ materially is included in the Proxy. Copies of Crescent’s filings with the SEC are available publicly on the SEC’s website at www.sec.gov or may be obtained by contacting Crescent. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking statements are made only as of the date hereof, and neither Crescent nor LiveVox undertake any obligations to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Certain metrics included in this Presentation are presented on a pro forma basis to include results of acquired businesses as if such acquisitions had been completed as of January 1 of the applicable year of the acquisition. In addition, this Presentation includes references to non-GAAP financial measures, including but not limited to Gross Margin and EBITDA, please see appendix for a reconciliation of non-GAAP financial measures. Such non-GAAP measures should be considered only as supplemental to, and not as superior to, financial measures prepared in accordance with GAAP. Additionally, to the extent that forward-looking non-GAAP financial measures are provided, they are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Neither Crescent nor LiveVox nor any of their respective directors, officers, employees, advisors, representatives or agents makes any representation or warranty of any kind, express or implied, as to the value that may be realized in connection with the Transaction, the legal, regulatory, tax, financial, accounting or other effects of a Transaction or the accuracy or completeness of the information contained in this Presentation, and none of them shall have any liability based on or arising from, in whole or in part, any information contained in, or omitted from, this Presentation or for any other written or oral communication transmitted to any person or entity in the course of its evaluation of the Transaction. Only those representations and warranties that are expressly made in a definitive written agreement with respect to the Transaction, if executed, and subject to the limitations and restrictions specified therein, shall have any legal effect. This Presentation contains information derived from third party sources, including research, surveys or studies conducted by third parties, information provided by customers and/or industry or general publications. While we believe that such third party information is reliable, we have not independently verified, and make no representation as to the accuracy of, such third party information. This Presentation contains financial forecasts. These projections are for illustrative purposes only and should not be relied upon as being necessarily indicative of future results. Inclusion of the prospective financial information in this presentation should not be regarded as a representation by any person that the results contained in the prospective financial information will be achieved. LTV is calculated as subscription gross margin divided by gross churn. CAC is calculated as trailing twelve months S&M expense divided by quarter 0 subscription revenue annualized less quarter 4 subscription revenue annualized. This Presentation contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this presentation may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. Important Information about the Transaction and Where to Find It This Presentation may be deemed solicitation material in respect of the Transaction. The Transaction will be submitted to the stockholders of Crescent for their approval. In connection with such stockholder vote, Crescent has filed the Proxy with the SEC and is mailing the Proxy to its stockholders as of the established record date in connection with Crescent’s solicitation of proxies for the special meeting of the stockholders of Crescent to be held to approve the Transaction. This Presentation does not contain all the information that should be considered concerning the proposed Transaction and the other matters to be voted upon at the annual meeting and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. Crescent’s stockholders and other interested parties are urged to read the Proxy and any other relevant documents that are filed or furnished or will be filed or will be furnished with the SEC carefully and in their entirety in connection with Crescent’s solicitation of proxies for the annual meeting to be held to approve the Transaction and other related matters, as these materials will contain important information about LiveVox and Crescent and the proposed Transaction. Copies of the Proxy can be obtained, without charge, at the SEC’s website at http://ww.sec.gov, at Crescent’s website at http://www.crescentspac.com or by directing a request to Crescent Acquisition Corp, 11100 Santa Monica Blvd., Suite 2000, Los Angeles, CA 90025. Participants in the Solicitation Crescent and LiveVox, and their respective directors and executive officers, may be deemed participants in the solicitation of proxies of Crescent’s stockholders in respect of the Transaction. Information about the directors and executive officers of Crescent and the directors and executive officers of LiveVox and more detailed information regarding the identity of all potential participants, and their direct and indirect interests, by security holdings or otherwise, is set forth in the Proxy. Additional information regarding the identity of all potential participants in the solicitation of proxies to Crescent stockholders in connection with the proposed Transaction and other matters to be voted upon at the special meeting, and their direct and indirect interests, by security holdings or otherwise, is included in the Proxy. Investors may obtain such information by reading the Proxy.

Executive Summary (1) Usage multiplier defined as total revenue divided by contracted revenue. Adding High Quality, Independent Board Members: Leslie Campbell (Board member at Coupa and PetMed Express), Susan Morisato (Former President – Insurance Solutions, United Health Care) and Kathleen Pai (Chief People Officer, SolarWinds / N-Able) Added Dedicated IR Professional: Alexis Waadt joined in April from Qualcomm and brings 20+ years of experience Shareholder Vote Scheduled for June 16 Reiterating Guidance: Revenue on track for $129 million for 2021 Contracted Revenue is Accelerating: 25% contracted growth forecast for 2021, higher growth rate projected for contracted revenue in 2022 Usage Expected to Normalize as COVID Fades: End of direct-to-consumer stimulus and collections forbearances along with a general return to normal economic activity Potential for Usage-Driven Upside to 2022 Plan: 1.4x usage multiplier(1) assumed in revenue plan of $163 million (consistent with LTM COVID-Affected Period and less than 1.5x+ pre-COVID) Q1 Bookings Exceeded Plan: 119% Growth YoY and 107% of plan Strong Execution on Expanding Go To Market Capacity: Marketing lead generation, sales team hiring, and channel partnership development efforts all tracking on or ahead of plan Revenue on Plan: Q1 contracted revenue +23% YoY (102% of plan); usage rates remain below historical norms due to the pace of the COVID recovery Q1 Update Outlook Governance and Leadership

Q1 Update

Go To Market: Q1 ‘21 Bookings Ahead of Plan Broad-based outperformance of Q1 ’21 bookings plan positions LiveVox well to achieve its 2021 contracted revenue plan Key Enablers Of Momentum Strong YoY Growth Bookings Ahead of Plan 119% New Bookings Growth YoY 107% Bookings Attainment Relative To Plan Accelerating demand for non-voice and analytics products Continued optimization of product capabilities and packaging Substantial go to market investment Key Sales Metrics

Go to Market: Key Initiatives Tracking Toward Plan 4,500 sub-agents 3,000+ independent sales partners We have made significant progress against all KPIs required for us to achieve our 2021 and 2022 bookings plans Channel Sales: Strong Momentum With New Partners Direct Sales: Significant Increase in Quota Capacity Marketing: Lead Generation Ahead of Plan YoY Growth in Quota Carrying Headcount Q1 Marketing Qualified Leads (“MQLs”) Attainment Relative To Plan

Overview Reminder: Two-Pronged Revenue Model Contracted Revenue (~2/3) Contracted revenue is a combination of (1) per-seat per month fees, and (2) minimum contracted usage billing that is billed regardless of consumption every month Usage revenue is billed for customer consumption above their contracted minimum. Premium pricing applies to usage revenue. Usage Revenue (~1/3) Key Metrics Components Bookings Usage Multiplier (Total Revenue / Contracted Revenue) Usage component is a strategic selling tool for landing and expanding with clients Note: Usage includes immaterial amounts of other revenue including professional services.

Revenue: Q1 Results on Plan Based on Strong Contracted Revenue Growth We continue to deliver above plan contracted revenue and expect usage to return to historical levels as COVID abates and the economy returns to normal Outperformance on Contracted (+23% YoY) COVID Driving Usage Below Historical Levels Repeated Stimulus: Collections activities were completed in record times given excess cash delivered to consumers, reducing overall platform usage Collections Forbearances: Student loans and mortgages at the federal level; private lenders have reduced collections activity in parallel ($ in millions) Note: Usage includes immaterial amounts of other revenue including professional services.

Contracted: Reacceleration After a COVID-Driven Slowdown in 2020 Strong bookings supports continued acceleration of contracted revenue COVID Contracted Revenue (Trailing 8 Quarters)

Note: Usage includes immaterial amounts of other revenue including professional services. Usage: Historically Stable Usage Multiplier Expected to Recover Post-COVID Pre-COVID: Usage Multiplier consistently 1.5x+ COVID: Usage Multiplier at lowest levels in Company history Total Revenue (Trailing 8 Quarters)

2021 and 2022 Outlook

Actual Forecast Contracted: Growth is Accelerating LiveVox is tracking on plan for 2021 and 2022 contracted revenue projections Annual Contracted Revenue

Usage: On Track for Full Year Plan Despite Pace of COVID Recovery 2021 Revenue Forecast No additional direct-to-consumer stimulus Stimulus-driven high consumer savings rates revert to mean throughout the year on the back of strong spending Usage ramps throughout the year in response to normalized consumer credit environment Key Assumptions Supporting Forecast Note: Usage includes immaterial amounts of other revenue including professional services. Usage Multiplier Contracted Growth $4M revenue go-get to achieve contracted plan (95% visibility) Contracted revenue has reaccelerated; usage recovery is still in early innings

2022 Outlook: A “Return to Normal” Provides Upside Potential YoY Growth for 2022 is calculated relative to $129M 2021 Plan. Note: Usage includes immaterial amounts of other revenue including professional services. Current 2022 Revenue Forecast Illustrative 2022 Revenue Assuming 2019 Average Usage Multiplier We believe that platform usage will return to historical levels as COVID abates, stimulus exits the system, and global economic activity returns to normal 1 1

EX-99.3

Exhibit 99.3

BUSINESS UPDATE PRESENTATION TRANSCRIPT

Alexis Waadt, Vice President and Head of Investor Relations of LiveVox

Welcome to today’s business update presentation. Joining us on this presentation are Louis Summe, Chief Executive Officer and Co-Founder of LiveVox; and Gregg Clevenger, Executive Vice President and Chief Financial Officer of LiveVox.

We would first like to remind everyone that this presentation contains forward-looking statements, including, but not limited to, LiveVox’s expectations or predictions of financial and business performance and industry outlook.

Forward-looking statements are inherently subject to risk, uncertainties, and assumption and they are not guarantees of performance. We encourage you to read the definitive proxy statement filed by Crescent Acquisition Corp with the SEC and its other SEC filings for a discussion of the risks that can affect the proposed business combination between Crescent Acquisition Corp and LiveVox, Crescent Acquisition Corp and LiveVox’s businesses and the outlook of the combined company.

Crescent Acquisition Corp and LiveVox are under no obligation and expressly disclaim any obligation to update, alter or otherwise revise any forward-looking statements, whether it’s a result of new information, future events or otherwise, except as required by law.

This presentation is for informational purposes only and shall not constitute an offer to buy any securities or a solicitation of any vote in any jurisdiction pursuant to the proposed business combination or otherwise. Nor shall there be any sale of securities in any jurisdiction which the offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

With that, I’ll turn the call over to Mr. Summe.

Louis Summe, Co-Founder and CEO of LiveVox

Hello, this, is Louis Summe. I’m going to start off with a high-level update on the business and then hand it over to Gregg to go through more of the details. First, on our first quarter results.

We had a strong bookings quarter, up 119% over the first quarter of last year and about 7% higher than our internal plan for the quarter. In addition, we have made substantial progress in building out our capacity in our sales and marketing by ramping up our marketing lead generation and direct sales teams,

and by deepening our agent channel relationships – all of which are tracking ahead of our plan. In fact, I have never felt better about the breadth, depth and quality of our sales pipeline. Our revenue was on plan for the quarter with a strong out-performance relative to plan in our Contracted Revenue which grew 23% year-over-year, although our Usage Revenue still remains below pre-COVID levels and Gregg will talk about that a little bit more.

Our outlook for the business remains strong and we are reiterating our 2021 revenue guidance of $129 million. We feel good about the growth trajectory of Contracted Revenue which we forecast will grow 25% this year and an even higher growth rate in 2022. We expect our Usage Revenue to normalize as the impact of COVID fades, as direct-to-consumer stimulus checks are spent, and as the financial system returns to more a normal operation level. Looking ahead to 2022, our forecast assumes usage remains well below pre-COVID levels, so we’re confident in our forecast and, should usage return to those pre-COVID levels, we see upside potential to the $163 million of revenue forecasted for next year.

We’ve also made great progress in preparing to be a public company by expanding our board with three seasoned additions who will round out our existing board with strong public company and software company expertise. We’ve also brought on a seasoned investor relations leader who is already working closely with our management team and shareholders to enhance the quality and flow of communication as we emerge from this transaction as a public company. As you all probably know by now, we mailed our definitive proxy statement to shareholders on May 14^th and have scheduled a shareholder vote for June 16^th.

With that, I will hand it over to Gregg to go through more of the details.

Gregg Clevenger, Executive Vice President and CFO of LiveVox

Thank you, Louis.    

As Louis mentioned, we had a solid first quarter this year for new sales bookings with growth of nearly 120% versus the first quarter of last year. We did expect the first quarter bookings this year to outperform last year given the impact that the early days of the COVID pandemic had on our first quarter bookings last year, but we over-achieved relative to our own plans and expectations by 7%, which helps to put us well on-track for achieving our Contracted Revenue plan for 2021. Our bookings momentum is contributed to by the payback we are already seeing in our key strategic initiatives

including the investments we’ve made to broaden our portfolio of non-voice products and the continued optimization and packaging of those products, and then putting increased sales and marketing investments behind those products to catch customers early in their buying cycles to demonstrate our product capabilities and ROI.

Slide 6 gives you a view of some of our key go-to-market initiatives in the first quarter. The first step to filling a new sales pipeline is marketing qualified leads, or MQLs, and we beat our MQL plan for the quarter by 5%. This gives us confidence in the top end of our new sales funnel, which in turn bodes well for meeting our new sales objectives later in the year, as a portion of these MQLs mature into contracted new sales later in the year. The growth in the number of new logos in the pipeline as well as the breadth of product demand gives us confidence that our marketing efforts are leading to one, increased presence and exposure, and two, greater demand across our bundled products due to our historical investment in R&D.

We are also making progress in building out our direct sales channel. As we have discussed, we plan to more than double our quota-carrying sales reps by the end of 2022 relative to where we ended up at the end of 2020, and we have already added 23% to our quota capacity over the course of the first quarter, which is exactly where we had planned to be at this time.

And lastly, expanding our presence in the indirect, or agent, channel is a key go-to-market initiative for us, and we are very excited about the progress we have made to date with these important business relationships, particularly with Telarus and Intelisys. As we sit here today, new sales opportunities sourced from the agent channel comprise about 5% of our total pipeline and over 10% of our Stage 4 and 5 pipeline, which are the stages closest to closing. In fact, we’ve already closed two new deals through our agent channel partners which we believe is quite an achievement given that we established these master-agent partnerships just a couple of months ago. This early traction bodes well for our 2022 target of 26% Contracted Revenue growth.

Before getting into our first quarter results and outlook going forward, on slide 7, I want to remind you of our two-pronged revenue model, specifically our Contracted Revenue and our Usage Revenue. Our Contracted Revenue is largely driven by new sales bookings while our Usage Revenue is related to customers using our products above and beyond what was committed to under their contracts. You can

think of Usage Revenue in terms of a Usage Multiplier of Total Revenue divided by Contracted Revenue. So, simplistically, prior to COVID, we generated more than 50 cents of Usage Revenue for every dollar of Contracted Revenue which was a Usage Multiplier of over 1.5x. Unique within our industry, we see the usage component of our contracts as a key differentiator as it allows new customers to come onto the platform with a lower up-front commitment and then have the ability to increase that commitment over time. As we have discussed previously, our sales motion relies on a land and expand strategy, and we believe that the usage component of our business has been a strategic selling tool in our acquisition of new logos. So, with that refresher, let’s move to slide 8 and talk about our results for the first quarter.

In short, our first quarter was on plan due to strength in our Contracted Revenue, which grew 23% over the first quarter of last year to $20.8 million, above our internal plan. Our Usage Revenue continues to rely on a steady COVID recovery, and ended the quarter slightly below plan and down year over year to $7.2 million. We expected that Usage Revenue this quarter would still be substantially below the pre-COVID levels that we’re comparing to, but unforeseen additional consumer stimulus packages and continued forbearances on certain student loans and mortgages have all led to lower usage levels. The fact is that COVID continues to affect our customer’s call volumes and thus our Usage Revenue and we cannot predict at this time when any of these COVID-related impacts to our Usage Revenue will get back to normal. However, as the economy moves towards normal and the COVID-related impacts I described ease, and our customers get back to a more normal, pre-COVID, operating cadence, we expect that our Usage Revenue will return to a more normal 1.5x plus multiplier we experienced before early last year.

So, summing up the out-performance in Contracted Revenue and the under-performance in Usage Revenue, our Total Revenue was on plan at $27.9 million for the quarter, 5% higher than the first quarter of last year.    

Moving on to slide 9, you can see that our Contracted Revenue has reaccelerated back up to our pre-COVID growth levels in the past two quarters, after the initial negative impact of COVID early last year.

Slide 10 illustrates a different story for our Usage Revenue which was at an all-time low in terms of the Usage Multiplier in the first quarter of this year due to the factors described on Slide 8. As discussed

earlier, it’s impossible for us to predict with any certainty when the financial system returns to normal operations, but we do expect the Usage Multiplier to move to pre-COVID levels of 1.5x plus, and when that does happen it will give us a strong revenue snap-back.

Let’s move to Slide 12 and talk about where we see revenue going from here. First, our Contracted Revenue is tracking to plan for this year and next at $90 and $113 million, respectively, with annual growth rates of 25% and 26%, respectively, accelerating from our Contracted Revenue growth rates in the past couple of years.

Based on our Contracted Revenue forecast for which we have 95% visibility to at this point in the year, Slide 13 shows that we continue to forecast $129 million in Total Revenue this year assuming that there is no new direct-to-consumer stimulus and stimulus-driven high consumer savings rates revert back to more normal levels on the back of pent-up demand and strong consumer spending, and usage-driven activity from our customers picks back up in response to a more normal credit environment. Given our forecasted Contracted Revenue, $129 million in Total Revenue would be achieved this year with about a 1.4x Usage Multiplier, still below a more normal pre-COVID level.

On slide 14, you can see that we are on track to achieve our previously forecasted $163 million in Total Revenue in 2022 assuming that we maintain the COVID-impacted Usage Multiplier of about 1.4x. In fact, we could out-perform on 2022 Total Revenue with a more normal pre-COVID Usage Multiplier of about 1.5x, potentially hitting $174 million for the year, which would be 35% higher than $129 million this year. We expect that usage levels will return to pre-COVID levels as stimulus is wrung from the system and businesses and consumers get back to normal, but as I said earlier, it’s impossible for us to predict at this point when things will be back to normal or what the path will look like to get there from here.

In summary, when we look ahead to 2022, driven in large part by the strength of our bookings momentum and a recovery from COVID, we feel really good about our current forecast.

That’s it for the update. Thank you for your time, we really appreciate your support.